Natural bioactive products in the regulation of bone metabolism and regeneration
Frontiers in Pharmacology · 14.11.2025 · 16
DOI: 10.3389/fphar.2025.1683279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.11.2025. Verfasst von Xinyi Ouyang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoporosis (OP) is a systemic skeletal disorder characterized by decreased bone mineral density (BMD), impaired bone microarchitecture, and an elevated risk of fragility fractures. Although conventional pharmacological agents—such as bisphosphonates, selective estrogen receptor modulators, and monoclonal antibodies—can attenuate disease progression, their long-term application is limited by adverse effects and suboptimal patient adherence. Consequently, there is growing interest in the development of safer, multi-targeted therapeutic strategies. Plant-derived bioactive products have garnered increasing attention due to their broad pharmacological profiles, including the promotion of osteoblastogenesis, suppression of osteoclastogenesis, regulation of bone–vascular coupling, and modulation of immune and oxidative stress pathways. Recent advances in biomaterial-assisted delivery systems have further improved the physicochemical stability, bioavailability, and tissue-specific delivery of these phytochemicals, thereby enhancing their therapeutic efficacy in bone regeneration. Although accumulated in vitro and in vivo studies suggest the bone-protective potential of these natural agents, clinical translation remains limited. Further mechanistic investigations and rigorously designed clinical trials are warranted to substantiate their efficacy and safety in human populations. This review summarizes recent progress in the mechanistic understanding of natural products involved in bone metabolism, with a particular focus on representative classes such as flavonoids, polyphenols, polysaccharides, glycosides, and terpenoids. In addition, we discuss the translational potential of integrating these agents with advanced drug delivery platforms, aiming to provide a theoretical framework and future research directions for the treatment of OP and related bone disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan University of Chinese Medicine, Changsha, China.
- The Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese and Western Medicine, Hunan…
- Hunan Key Laboratory of Traditional Chinese Medicine Prescription and Syndromes Translational Medicine, Hunan University of Chinese Medicine, Changsha, China.
- State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (Incubation), Science and Technology Innovation Center, Hunan University of Chinese Medicine, Changsha, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ouyang, X., Ma, Q., Zhou, C., Tang, J., Li, M., Qing, J., Lei, X., Huang, D., Liu, H., & Zhang, G. (2025). Natural bioactive products in the regulation of bone metabolism and regeneration. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1683279
Vancouver
Ouyang X, Ma Q, Zhou C, Tang J, Li M, Qing J, et al. Natural bioactive products in the regulation of bone metabolism and regeneration. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1683279
BibTeX
@article{Ouyang2025,
author = {Ouyang, Xinyi and Ma, Qiang and Zhou, Chang and Tang, Jiaqian and Li, Mengyuan and Qing, Jun and Lei, Xiaoming and Huang, Dan and Liu, Huiping and Zhang, Guomin},
title = {Natural bioactive products in the regulation of bone metabolism and regeneration},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1683279}
}
EUVIMED